Asia Pacific Breast Implants Market size crossed USD 320 million in 2021 and is estimated to showcase around 8% growth rate from 2022 to 2028.
Breast implant surgery is considered the most common technique to achieve breast augmentation and provide natural long-term results. Due to the presence of qualified plastic surgeons and clinics, Asia Pacific countries including South Korea are becoming popular destinations for cosmetic surgeries.
Get more details on this report - Request Free Sample PDF
According to data from Ever Healthcare Thailand, nearly 1 million plastic surgery operations are being conducted every year in South Korea, exclusive of the inbound medical tourists. This ever-increasing popularity of plastic surgery can be credited to the low costs of breast implantation in the country compared to western nations.
Likewise, rapid technological innovation plays a crucial role in the production of advanced breast implants in terms of material, fill volumes, and design, leading to reduced wrinkling and rippling. Surgeons operating in the APAC have also maintained a track record of delivering promising outcomes and creating advanced technologies that increase the efficiency of the surgery and reduce recovery time.
The adoption rate of saline breast implants has surged in the recent years, due to their beneficial properties, such as the requirement for small incisions and adjustability for improved breast symmetry.
With the growing prevalence of breast cancer, the rate of mastectomy will subsequently rise. According to the GLOBOCAN 2020 survey, the incidence rate of breast cancer reached 13.5% in India alone. This factor may encourage patients who had undergone mastectomy or mammoplasty surgeries to opt for breast reconstruction procedures to restore breast volume and shape.
The textured breast implants market in Asia Pacific is estimated to observe high growth till 2028, as they offer key features like stabilization and reduction of capsular contracture. With the escalating cases of breast cancer and the robust demand for breast reconstruction, the consumption of textured implants will rise considerably.
The rate of breast implantation procedures across hospitals will likely increase during the forecast period, considering the range of diagnostic, curative, and rehabilitation services being provided. As compared to clinics and other healthcare settings, hospitals also have a larger infrastructure and resources, while offering greater safety and care.
China silicone breast implants market will exceed USD 100 million revenue by 2028. In the region, the prevalence of breast cancer has increased in recent years, requiring effective cancer prevention and control measures. As a result, the development of breast implants filled with silicone gel will rise, making them a great fit for people who want to restore breast volume and shape after a mastectomy. Furthermore, the progress in medical technology will also influence the trend of adopting breast augmentation and reconstruction surgeries.
Prominent participants operating across the Asia Pacific breast implants market include Hansbiomed Co. Ltd., Shanghai Kangning Medical Device, Silimed, Guangzhou Wanhe Plastic Materials Co. Ltd., GC Aesthetics, Polytech Health & Aesthetics, Sebbin SAS, Cereplas, Laboratory Arion, Allergan Plc, Establishment Labs SA, Ideal Implant Inc., Mentor Worldwide LLC, and Sientra. These firms undertake strategic initiatives like new product launches, mergers, and acquisitions to expand their foothold across the market.